Lincoln College invites you to attend the Lincoln Leads Seminar Series 2020.
The Pathology seminar in the series explores the question: Shoud Antivaxxing be Illegal?
All tickets are free, but must be booked in advance at Eventbrite: www.eventbrite.co.uk/e/lincoln-leads-2020-tickets-87627477143
Panel:
Professor Jordan Raff (Fellow of Lincoln College, Oxford)
Dr Sabine Jaccaud (Director of Cambridge Communications, AstraZeneca)
Flurin Caviezel (DPhil, Oncology)
Chair:
Anna Huhn (DPhil, Molecular Cell Biology)
When: Thursday, 23rd January, 5.45 – 7pm. Wine Reception from 5.15pm
Where: Oakeshott Room, Lincoln College, Turl St, Oxford
———————————————————————————————————————————————
The Lincoln Leads Seminar Series 2020 takes place on Thursday evenings during Hilary term at Lincoln College, Oxford. Each panel features an Alumnus/na, a Fellow, and a Student of the College, who will respond to a topical question linked to their research or professional experience. Following a wine reception at 5pm, each seminar will start at 5.45pm, culminating in a lively Q&A session. We have a fantastic group of panellists scheduled for the series, who aim to invite non-specialist audiences into their spheres of expertise. We therefore hope that you are eager to join them in conversation, and learn more about the exciting and diverse research connected to Lincoln.
Please see below for further details of our speakers:
F: Professor Jordan Raff
Jordan Raff is Professor at the Sir William Dunn School of Pathology in Oxford. He studied Biochemistry at Bristol University and did his PhD in the Department of Biochemistry at Imperial College London, where he first started to work on centrosomes and cell division in the fruit fly Drosophila melanogaster. He has continued to work on these questions throughout his scientific career, first as a post-doctoral fellow with Bruce Alberts in the Department of Biochemistry and Biophysics at the University of California, San Francisco, then as a Wellcome Trust or CRUK funded group leader at the Gurdon Institute in Cambridge. He moved to Oxford in 2009 to take up the César Milstein Chair of Cancer Cell Biology. He has been President of the British Society for Cell Biology (2011-2017), Editor in Chief at the not-for-profit Open Access Journal Biology Open (2011-2018), and has always taken a keen interest in promoting the public understanding of science.
A: Dr Sabine Jaccaud
Sabine Jaccaud is Director of Cambridge Communications at AstraZeneca. She arrived at Lincoln in 1991 from Geneva, as a Berrow Scholar and completed an MPhil and DPhil in Modern English and Comparative Literature. Her career is in Corporate Affairs and strategy consulting, with a focus on change communications, crisis management and research-led campaigns, primarily with global organisations undergoing radical transformation. She has worked in house and as a consultant, independent advisor, non-exec director, public speaker and mentor. Having transferred from academia to a corporate career, she is strongly committed to working across disciplines and advocating for collaborative practices. Sabine currently lives in Cambridge and heads up Corporate Affairs for AstraZeneca’s move of its global HQ to the city, and development of an R&D centre in the context of the role multi-sector clusters play in life-science innovation. She sits on Lincoln’s Rector’s Alumni Council and is a trustee at Kettle’s Yard, a University of Cambridge Museum.
S: Flurin Caviezel
Flurin Caviezel is a PhD Student at the Department of Oncology at Oxford University. He studied cell biology at the University of Bern in Switzerland and completed his Master’s degree in Immunology and Microbiology in 2018. For his Master’s Thesis, he tested a novel vaccine based on virus-like particles against cat-hair allergy in the context of human cells. At present, he is in his second year of his DPhil in the Department of Oncology and works in Professor Len Seymour’s group. His main research area is to target cancer using oncolytic viruses in order to deliver therapeutic agents directly to the tumour microenvironment.
